Auto Transplantation of Wisdom Teeth

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-50
SponsorCleveland Dental Institute

About this trial

Autotransplantation emerges as a viable alternative to tooth extraction and prosthetic restoration when conventional endodontic treatments are unfeasible or contraindicated. The success of autotransplantation is influenced by diverse factors, including root development stage, tooth morphology, surgical technique, extraoral duration, recipient socket shape, recipient bed vascularity, and periodontal ligament cell vitality. Preserving periodontal ligament quality and achieving tissue adaptation are pivotal for successful tooth transplantation. Successful donor tooth replacement is influenced by variables like fitting attempts, alveolus-root distance, extra-alveolar time, surgical skill, and extraction trauma intensity.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

male and female

aged between 20 and 50 years

devoid of systemic ailments

complying with the study procedures

Disqualifiers

systemic diseases that might impede the healing process

Patients with pacemakers

Individuals harboring allergies to medications or antibiotics

active smokers

Trial design

Design model

Parallel

Treatments tested in this trial

  • Autotransplantation with PRF

    Procedure/Surgery

    Autotransplantation of Wisdom teeth to the extracted socket of removed broken down posterior teeth with the application of PRF

  • Autotransplatation Only

    Procedure/Surgery

    Autotransplantation of Wisdom teeth to the extracted socket of removed broken down posterior teeth.

Treatment groups

20 Participants
are divided into 2 treatment groups
Group A: Autotransplantation with PRFExperimental treatment 1 intervention
Group B: Autotrasplantation onlyActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Radiographic success

The success of auto-transplanted immature third molars with and without Platelet-Rich Fibrin will be assessed over a year period.

Time frame
one year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.